首页> 外文期刊>Analytical chemistry >Evaluation of UV-C Decontamination of Clinical Tissue Sections for Spatially Resolved Analysis by Mass Spectrometry Imaging (MSI)
【24h】

Evaluation of UV-C Decontamination of Clinical Tissue Sections for Spatially Resolved Analysis by Mass Spectrometry Imaging (MSI)

机译:临床组织切片UV-C去污的评价对质谱成像(MSI)的空间分辨分析

获取原文
获取原文并翻译 | 示例
       

摘要

Clinical tissue specimens are often unscreened, and preparation of tissue sections for analysis by mass spectrometry imaging (MSI) can cause aerosolization of particles potentially carrying an infectious load. We here present a decontamination approach based on ultraviolet-C (UV-C) light to inactivate clinically relevant pathogens such as herpesviridae, papovaviridae human immunodeficiency virus, or SARS-CoV-2, which may be present in human tissue samples while preserving the biodistributions of analytes within the tissue. High doses of UV-C required for high-level disinfection were found to cause oxidation and photodegradation of endogenous species. Lower UV-C doses maintaining inactivation of clinically relevant pathogens to a level of increased operator safety were found to be less destructive to the tissue metabolome and xenobiotics. These doses caused less alterations of the tissue metabolome and allowed elucidation of the biodistribution of the endogenous metabolites. Additionally, we were able to determine the spatially integrated abundances of the ATR inhibitor ceralasertib from decontaminated human biopsies using desorption electrospray ionization-MSI (DESI-MSI).
机译:临床组织标本通常未经筛查,准备组织切片以通过质谱成像(MSI)进行分析可能会导致潜在携带感染性负载的颗粒雾化。我们在此提出一种基于紫外线-C(UV-C)光的去污方法,以灭活临床相关病原体,如疱疹病毒科、帕波病毒科人类免疫缺陷病毒或SARS-CoV-2,这些病原体可能存在于人体组织样本中,同时保留组织内分析物的生物分布。发现高水平消毒所需的高剂量UV-C会导致内源性物种的氧化和光降解。研究发现,较低的UV-C剂量维持临床相关病原体的灭活,以提高操作员的安全性,对组织代谢组和外源性物质的破坏性较小。这些剂量对组织代谢组的改变较小,并允许阐明内源性代谢产物的生物分布。此外,我们能够使用解吸电喷雾电离MSI(DESI-MSI)从净化的人体活检中确定ATR抑制剂ceralasertib的空间整合丰度。

著录项

  • 来源
    《Analytical chemistry》 |2021年第5期|共9页
  • 作者单位

    Department of Metabolism Digestion and Reproduction Faculty of Medicine Imperial College London;

    Imaging and Data Analytics Clinical Pharmacology and Safety Sciences R&

    D;

    Safety Health and Environment (SHE) Cambridge Operations;

    Safety Health and Environment (SHE) Cambridge Operations;

    Oncology Safety Clinical Pharmacology and Safety Sciences R&

    D AstraZeneca;

    Translational Medicine Oncology R&

    D AstraZeneca;

    Translational Medicine Oncology R&

    D AstraZeneca;

    Imaging and Data Analytics Clinical Pharmacology and Safety Sciences R&

    D;

    Imaging and Data Analytics Clinical Pharmacology and Safety Sciences R&

    D;

    Bioscience Discovery Oncology R&

    D;

    National Centre of Excellence in Mass Spectrometry Imaging (NiCE-MSI) National Physical Laboratory;

    Imaging and Data Analytics Clinical Pharmacology and Safety Sciences R&

    D;

    Department of Metabolism Digestion and Reproduction Faculty of Medicine Imperial College London;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 分析化学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号